NIH-funded research NIH-funded research

Fluoridated bottled water to prevent cavities in young children

Official title: Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water

Funded at Univ of North Carolina Chapel Hill · NIH-11364274 · Data updated 2026-11-12

A large, patient-facing trial tests whether having fluoridated drinking water in bottled form can prevent tooth decay in children from infancy to early childhood.

More Randomized Controlled Trial research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 17, 2020
Project endSeptember 16, 2029
Funding year2026
Award (this year)$1,529,558
NIH project number2UH3DE029169-07
Project IDNIH-11364274 on NIH RePORTER

Who could benefit from this research

Could help

Infants and young children in eastern North Carolina who are enrolled and have begun receiving study water deliveries.

Less likely to help

Children who do not consume the study water or who are not enrolled in the trial may not experience a direct benefit.

What this research studies

This project follows children from infancy in eastern North Carolina to see if drinking fluoridated bottled water reduces cavities in their primary teeth. It uses a placebo-controlled randomized design and collects annual dental exams and monthly study water deliveries, plus biomarker data from nail clippings to measure fluoride exposure. The study aims to provide clear, real-world evidence about the effectiveness of fluoridated water delivered in bottles, which could influence public health recommendations and water policies. Participants will receive regular visits and teeth exams over about 3.5 years to track changes in dental health.

Why it matters

Potential benefit: If successful, the trial could confirm a simple, scalable approach to reduce early childhood tooth decay.

How similar studies have gone: This is a pioneering placebo-controlled RCT for fluoridated drinking water and positive results would be a major advancement beyond prior observational evidence.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Slade, Gary Douglas — Univ of North Carolina Chapel Hill
  • Study coordinator: Slade, Gary Douglas

Related research

Other NIH-funded projects on the same topics.

  • Fluoridated bottled water to help prevent cavities in young children

    This project gives fluoridated bottled water to infants and young children in a community without fluoridated tap water to try to reduce tooth decay.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11160465

  • Evaluating the effects of fluoridated bottled water on dental health in children

    This study is looking at whether drinking fluoridated bottled water can help prevent cavities in kids who live in places without fluoridated tap water, and it involves about 470 babies from Kinston, NC.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-10897119

  • Cognitive behavioral therapy and trazodone for insomnia phenotypes with high blood pressure

    A clinical study tests how CBT-I and the sleep drug trazodone work for adults with insomnia and high blood pressure, focusing on a specific sleep duration pattern.

    NIH research Pennsylvania State Univ Hershey Med Ctr · Hershey, United States · NIH-11635771

  • Shorter antifungal treatment for kids with candidemia

    A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606539

  • Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia

    This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606535

  • Shorter antifungal treatment for kids with candidemia

    A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.

    NIH research Arkansas Children's Hospital Res Inst · Little Rock, United States · NIH-11606531

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.